All posts tagged
MorphoSys’ First Lanthipeptide Completes Phase I Successfully
Way to Success: What Role does Company Culture Play in Biotech?
Which EU Immuno-Oncology Company are you Cheering for?
Video Interview: How Morphosys Grew Into a Billion-Euro Biotech
What are the Best Countries to Recruit Biotech Talents in 2017?
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
Infographic: The Biggest Biotech Company in Each European Country
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
These are 10 of the Hottest Biotech Hubs in Europe
How is European Immuno-Oncology fighting Blood Cancer?
Labiotech UG, All Rights Reserved -
Send this to friend